SSG Advises Eiger BioPharmaceuticals, Inc. in the Sale of Zokinvy® Program Assets to Sentynl Therapeutics, Inc.
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Eiger BioPharmaceuticals, Inc. (“Eiger” or the “Company”) in the sale of substantially all of its assets related to the FDA-approved drug Zokinvy®, to Sentynl Therapeutics, Inc. The sale….
READ MORESSG Advises the Chapter 7 Trustee of ContraFect Corporation in the Sale of Substantially All Intellectual Property Assets to Aurobac Therapeutics SAS
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to the Chapter 7 Trustee of ContraFect Corporation (“ContraFect” or the “Company”), in the sale of substantially all intellectual property assets to Aurobac Therapeutics SAS. The transaction closed in….
READ MORETeresa C. Kohl Recognized with the M&A Advisor’s 2024 Leadership Award
Managing Director Teresa C. Kohl was presented with the M&A Advisor’s Leadership Award during the 18th Annual Turnaround Awards Gala in West Palm Beach, Florida on March 19. This prestigious award recognizes Teresa’s accomplishments throughout her career and the….
READ MORESSG Advises St. Cloud Capital LLC in the Sale of Renters Warehouse to GA Technologies
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to one of the funds of St. Cloud Capital LLC (“St. Cloud”), the senior secured lender of Renters Warehouse (the “Company”), a United States-based single-family home rental services platform…..
READ MORESSG Advises Christmas by Krebs Corporation in the Sale of Substantially all of its Assets to The Gerson Companies
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Christmas by Krebs Corporation (“CBK” or the “Company”) in the sale of substantially all of its assets to The Gerson Companies. The transaction was effectuated pursuant to Article 9….
READ MORE